Home / Intelligence

Type
  • All
  • Analyst Reports
  • Blog
  • Briefs
  • Case Studies
  • Podcasts
  • Scientific Publications
  • Webinars
  • White Papers
Featured Topic
  • All
  • AIML
  • Analytics
  • APAC
  • Benchmarking
  • Biosimilars
  • CAR-T
  • Cell and Gene Therapy
  • Commercial Operations
  • Competitive Intelligence
  • Contract Analytics
  • Corporate Strategy
  • COVID-19
  • Customer Engagement
  • Data Management
  • Digital Therapeutics
  • Diversity
  • Emerging Life Sciences
  • Europe
  • Evidence Strategy (HEOR)
  • Field Force
  • Forecasting
  • Generative AI
  • Incentive Compensation
  • Inflation Reduction Act
  • Insights
  • International
  • LatAm
  • Launch and Brand Excellence
  • Learning and Development
  • Market Research
  • Marketing
  • Medical Affairs
  • MedTech
  • New Product Planning
  • NRDL
  • Omnichannel
  • Oncology
  • Patient Centricity
  • Patient Finding
  • Patient Services
  • Performance Tracking
  • Pricing and Access
  • Product Demos
  • Rare Disease
  • Real-World Evidence
  • Scientific Publications
  • Sustainability
  • Talent Acquisition and Retention
  • United States
  • Value Communication
Search

Webinars

Part D in Peril: The Inconvenient Math of IRA Part D Redesign 

August 18, 2025 | 12:00 – 12:45 (UTC +8:00)/Asia or 12:00 – 12:45 CET/Europe

Medicare Part D is undergoing its most significant transformation in decades largely driven by the Inflation Reduction Act (IRA). What does this mean for pharmaceutical manufacturers? Join us for an engaging discussion with Max Hunt, Partner at Trinity Life Sciences, and special guest Dan Simenc, clinical and actuarial expert at Milliman, as they provide perspectives on recent developments and future expectations for Medicare Part D and Medicare Advantage.

Sign Up Now

Webinars

Trinity CloudCast: Lunch and Learn

Available On Demand

Unlock forecasting value with revolutionary technology Collaborate on and update models in the cloud Incorporate stakeholder feedback into forecasts on the fly Manage effective and efficient stakeholder communication Trinity CloudCast is an online solution, delivered with Trinity’s best-in-class forecasting services, that streamlines forecasting activities to drive effective and efficient business decisions across life sciences organizations. Come join us for a virtual discussion, where Susheel Sukhtankar, Partner & Head of Commercial Analytics, Adrian Watson, Director of Forecasting and Akash Kundu, Associate…

Watch Now

Webinars

Elevating Commercialization in China Part 1: The Path to Launch

Available On Demand

The pharmaceutical market in China has experienced tremendous growth over the past several decades and is becoming increasingly important. While many life sciences organizations consider China to be a ‘must win’ market, commercial success can be elusive. Despite the large patient base and recent economic and political tailwinds driving the advancement of the healthcare industry, sales for innovative drugs in China are often only a fraction of those in the U.S. The complex and rapidly evolving market dynamics require companies…

Watch Now

Webinars

A Practical Omnichannel Vision: From Strategy to Execution and Optimization

Available On Demand

The omnichannel-driven approach to promotional activity is being shaped by evolving dynamics in the life sciences market: The behavior of the target audience is changing. Customers have an increased desire for personalized content and on-demand access. Proliferation of data and AI is introducing more complexity to planning, execution and adoption of new ways of doing things. Economic pressures and fear of message fatigue is leading promotional efforts to become more orchestrated and cost-efficient. What considerations should life sciences organizations make…

Watch Now

Scientific Publications

ISPOR US 2023 Research Posters

Health Equity Frameworks – Healthcare System Actions and Priorities Gulaid A1, Goldman E2, Skaar J1, Dehipawala S3 1Trinity Life Sciences, New York, NY, USA, 2Trinity Life Sciences, Waltham, MA, USA, 3Trinity Life Sciences, Bellerose, NY, USA Health equity has been defined as attainment of the highest level of health for all people, regardless of race, ethnicity, disability, and/or other factors affecting access to care and health outcomes in healthcare delivery. Health equity is becoming a priority for payers and hospitals…

Read Now

Webinars

Goodbye Humira, Hello Future

Available On Demand

Biosimilar versions of adalimumab have launched in the U.S., ending blockbuster therapy Humira’s lengthy market exclusivity and long-running commercial success. In parallel, in the creation of the Inflation Reduction Act (IRA), the U.S. joins Europe and other major markets in constraining the opportunity for medicines during their market exclusivity window. The life sciences industry now seeks to understand how the vision for commercial success will evolve while in parallel navigating new artificial intelligence (AI) and other general-purpose technologies (GPTs) technologies…

Watch Now

Blog

The Last Mega Blockbuster Drug: Goodbye Humira, Hello Future

Published April 21, 2023

Executive Summary Biosimilar versions of adalimumab have launched in the U.S., ending blockbuster therapy Humira’s lengthy market exclusivity and long-running commercial success. In parallel, in the creation of the Inflation Reduction Act (IRA), the U.S. joins Europe and other major markets in constraining the opportunity for medicines during their market exclusivity window. Trinity’s Take These events usher in a new era for the life sciences industry, necessitating new thinking around development and commercialization strategy. Historic reliance on the U.S. market…

Read Now

Webinars

Developing Innovative, Patient-centric Services Using the Holistic Patient Journey

Available On Demand

Ensuring that Patient Support Services (PSS) are inspired by the patient and accurately reflect their key areas of need is an important facet of a patient-centric approach. Come join Jennifer Parr, Partner and Head of Patient Services & Patient Centricity at Trinity and Clare Gora, Vice President & Head of Analytics Client Development at Trinity as they discuss designing optimized PSS from holistic, robust patient journeys that identify the critical patient pain points, gaps, unmet needs and moments of meaning.…

Watch Now

Webinars

Far From Routine: Performance Tracking as a Source of Powerful Insight

Available On Demand

Assessing the impact of market events, advocacy, promotion and messaging is a key focus for Marketing and Brand leaders in life sciences. Stakeholder-perception tracking research is an often-overlooked strategic and tactical input as brands look to optimize their commercial performance. Come join Lara Lyeth, a Principal in Trinity’s Performance Tracking CoE, as she hosts a lively discussion on performance tracking with special guests Viplav Shukla, an Associate Director in Trinity’s Performance Tracking CoE, Monte Smith, a Managing Director in Trinity’s Brand &…

Watch Now

Blog

Highlights of the 2022 National Reimbursement Drug List (NRDL) Negotiation Outcome

Published March 10, 2023

Executive summary 83 non-traditional Chinese medicines successfully entered the National Reimbursement Drug List (NRDL) for the first time. This is a >20% increase from the 2021 and 2020 NRDL updates, indicating the growing interest of both manufacturers and payers to ensure reimbursement for novel therapies in China. The percentage of products achieving NRDL inclusion within one year of regulatory approval continues to increase steadily, from 24% in 2020 to 53% in the 2022 update, keeping up the strong momentum of…

Read Now

Webinars

Payer Predictions: Evolution of the U.S. Digital Therapeutics Reimbursement Landscape

Available On Demand

The digital therapeutics (DTx) market is growing rapidly, but a lack of clarity around their reimbursement framework in the U.S. means that there is limited coverage. DTx developers— and pharmaceutical organizations seeking an integrated digital offering— are left to wonder how the payer landscape will evolve as they strategize for the future. Join Trinity Life Sciences’ MedTech and Evidence, Value, Access and Pricing experts as they explore what the future DTx reimbursement landscape might look like, drawing upon detailed first-hand…

Watch Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.